EGFR and non-small cell lung carcinoma: The genetic alterations of epidermal growth factor receptor (EGFR) such as overexpression, exon 19 deletion, and exon 21 L858R substitution have been characterized as oncogenic drivers for NSCLC development [5,6,7].